Coughlin Stoia Geller Rudman & Robbins LLP (?Coughlin Stoia?) (http://www.csgrr.com/cases/inyx/) today announced that a class action has been commenced in the United States...
NEW YORK, July 12 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI), reported that the company's Chairman & CEO, Jack Kachkar, M.D., yesterday was approved as the debtor-in-possession lender for...
NEW YORK, April 16 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, reported...
NEW YORK, March 26 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company focused on niche drug- delivery technologies and products, reported today...
NEW YORK, March 19 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), a specialty pharmaceutical company focused on niche drug- delivery technologies and products, reported today...
NEW YORK, Jan. 31 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, announced...
NEW YORK, Jan. 25 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, reported...
NEW YORK, Dec. 21 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC:IYXI) (BULLETIN BOARD: IYXI) , a specialty pharmaceutical company focused on niche drug-delivery technologies and products, announced...
NEW YORK, Dec. 7 /PRNewswire-FirstCall/ -- Generex Biotechnology Corporation (NASDAQ:GNBT), a leader in treating metabolic diseases via drug delivery through the inner lining of the mouth, and...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 20500 | 1.0E-6 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 20500 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 13700 | 1.0E-6 | CS |
26 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 8220 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 4890 | 1.112E-5 | CS |
156 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 41383 | 9.322E-5 | CS |
260 | -0.001499 | -99.9333333333 | 0.0015 | 0.0124 | 1.0E-6 | 128725 | 0.00391573 | CS |
Symbole | Prix | Vol. |
---|---|---|
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,0046 (21,05%) | 877,98M |
HMBLHUMBL Inc (PK) | US$ 0,0009 (0,00%) | 395,38M |
RDARRaadr Inc (PK) | US$ 0,0013 (4,00%) | 197,64M |
GRLFGreen Leaf Innovations Inc (PK) | US$ 0,0002 (100,00%) | 179,47M |
HCMCHealthier Choices Management Corporation (PK) | US$ 0,000001 (0,00%) | 139,17M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales